COVID-19 | PharmaTimes

Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine

Emily Kimber — Tue, 22 Apr 2025 11:21:42 +0000

The SHIELD-Utah study compared Novavax’s vaccine to the Pfizer/BioNTech mRNA 2024-2025 vaccine

Ella Day — Wed, 09 Apr 2025 11:20:57 +0000

An estimated 7.5 million people will be invited to receive the booster

Jen Brogan — Wed, 17 Apr 2024 09:47:36 +0000

The findings suggest why children tend to experience milder symptoms compared to older adults

Jen Brogan — Fri, 01 Mar 2024 11:51:44 +0000

Different factors, such as illness duration and virus variant, impacted patients cognitive abilities

Jen Brogan — Thu, 08 Feb 2024 11:08:36 +0000

The committee has advised that the vaccine should be given to those at the highest risk

Jen Brogan — Fri, 02 Feb 2024 10:41:53 +0000

Dopamine neuron senescence is a hallmark of Parkinson’s disease

Jen Brogan — Mon, 29 Jan 2024 11:30:38 +0000

A total of 103,277 general and acute beds are now available to NHS patients

Jen Brogan — Tue, 02 Jan 2024 14:00:14 +0000

The programme is the only remote, digital delivery nursing home training programme for dementia

Jen Brogan — Mon, 11 Dec 2023 11:19:00 +0000

New data highlights the inequalities in emergency hospital rates and vaccinations

Jen Brogan — Mon, 20 Nov 2023 11:58:00 +0000

The OpenSAFELY platform will support the discovery of new treatments